Type 2 diabetes: pathogenesis and treatment (Q81541542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Type 2 diabetes: pathogenesis and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1

Michael Stumvoll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Barry J Goldstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Timon W van Haeften

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

9631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2153-2156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

Type 2 diabetes: principles of pathogenesis and therapy

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Two variants on chromosome 17 confer prostate cancer risk and the one in TCF2 protects against type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Common variants in WFS1 confer risk of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

A genome-wide association study identifies novel risk loci for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Variation in FTO contributes to childhood obesity and severe adult obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960932-0

7 January 2021

10.1016/S0140-6736(08)60932-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18586159%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference